Chris Cardon, the Flemish who wants to develop the ideal vaccine: "We aim for double protection."

February 09, 2021

The young Belgian company Ziphius vaccines targets the coronavaccine market with its innovative technology. It aims for the ideal world: an mRNA vaccine that is 100% effective and only requires one dose. CEO Chris Cardon firmly believes it is possible.